Sign inJoin waitlistJoin the waitlist

Craig Moskowitz

Clinical Lead · University of Miami/Jackson Health System

Credentials: · · · ·

History

University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present
ONCOLOGY SERVICE LINE Division · University of Miami/Jackson Health System
Present

Medical Oncology
1991–1993
Internal Medicine
1988–1991
Wayne State University School of Medicine
1984–1988

Research

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era
Journal of Clinical Oncology · 2010 · 1,355 citations
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma
Journal of Clinical Oncology · 2012 · 1,166 citations
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Journal of Clinical Oncology · 2017 · 791 citations

AZ
Andrew Zelenetz
89 papers
DS
David Straus
51 papers
PH
Paul Hamlin
51 papers · 2 as a fellow
AN
Ariela Noy
45 papers
CP
Carol Portlock
44 papers
Joachim Yahalom
43 papers
AM
Alison Moskowitz
40 papers · 4 as a fellow
Matthew Matasar
40 papers
SH
Steven Horwitz
31 papers
Heiko Schöder
28 papers
AK
Anita Kumar
24 papers
Lia Palomba
22 papers

Clinical trials

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
Principal investigator · Recruiting
University of Miami
2023–2026
Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
Principal investigator · Terminated · Phase 2
University of Miami
2020–2022
Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2008–2015
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2007–2013